<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">
 <list list-type="simple" id="olist0025">
  <list-item id="o0065">
   <label>a.</label>
   <p id="p0095">In case a person with diabetes develops fever, cough, running nose or dyspnoea, the appropriate health authority needs to be notified as testing for this disease is available at selected places only.</p>
  </list-item>
  <list-item id="o0070">
   <label>b.</label>
   <p id="p0100">The affected person needs to be isolated for 14 days or till the symptoms resolve (whichever is longer).Country-specific guidelines need to be followed.</p>
  </list-item>
  <list-item id="o0075">
   <label>c.</label>
   <p id="p0105">Majority of patients have a mild disease and can be managed at home. Hydration should be maintained and symptomatic treatment with acetaminophen, steam inhalation etc. can be given.</p>
  </list-item>
  <list-item id="o0080">
   <label>d.</label>
   <p id="p0110">Patients with type 1 diabetes should measure blood glucose and urinary ketones frequently if fever with hyperglycemia occurs. Frequent changes in dosage and correctional bolus may be required to maintain normoglycemia.</p>
  </list-item>
  <list-item id="o0085">
   <label>e.</label>
   <p id="p0115">Anti-hyperglycemic agents that can cause volume depletion or hypoglycemia should be avoided. Dosage of oral anti-diabetic drugs may need to be reduced. Patients should follow sick day guidelines and may need more frequent monitoring of blood glucose and drug adjustment.</p>
  </list-item>
  <list-item id="o0090">
   <label>f.</label>
   <p id="p0120">Hospitalised patients with severe disease need frequent blood glucose monitoring. Oral agents especially metformin and sodium glucose cotransporter-2 inhibitors need to be stopped.</p>
  </list-item>
  <list-item id="o0095">
   <label>g.</label>
   <p id="p0125">Insulin is the preferred agent for control of hyperglycemia in hospitalised sick patients.</p>
  </list-item>
 </list>
</p>
